SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-10-085507
Filing Date
2010-04-16
Accepted
2010-04-16 16:19:35
Documents
3
Period of Report
2010-05-21
Effectiveness Date
2010-04-16

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 227695
2 GRAPHIC g21238g26o57.jpg GRAPHIC 19979
3 GRAPHIC g21238g91x42.jpg GRAPHIC 6375
  Complete submission text file 0001193125-10-085507.txt   265782
Mailing Address 220 MIRACLE MILE SUITE 234 CORAL GABLES FL 33134
Business Address 220 MIRACLE MILE SUITE 234 CORAL GABLES FL 33134 (305) 529-2522
Catalyst Pharmaceutical Partners, Inc. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33057 | Film No.: 10754935
SIC: 2834 Pharmaceutical Preparations